Literature DB >> 35083485

Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology.

Massimo F Piepoli1,2, Marianna Adamo3, Andrea Barison2,4, Reinaldo B Bestetti5, Jan Biegus6, Michael Böhm7, Javed Butler8, Jonathan Carapetis9, Claudio Ceconi10, Ovidiu Chioncel11,12, Andrew Coats13, Maria G Crespo-Leiro14, Giovanni de Simone15, Heinz Drexel16,17, Michele Emdin2,4, Dimitros Farmakis18, Martin Halle19, Stephane Heymans20,21, Tiny Jaarsma22,23, Ewa Jankowska24, Mitja Lainscak25,26, Carolyn S P Lam27, Maja-Lisa Løchen28, Yuri Lopatin29, Aldo Maggioni30, Benedetta Matrone1, Marco Metra3, Katharine Noonan10, Ileana Pina31, Eva Prescott32, Giuseppe Rosano33, Petar M Seferovic34, Karen Sliwa35, Simon Stewart36, Alicia Uijl21,37,38, Ilonca Vaartjes23, Roel Vermeulen37, W M Verschuren39,40, Maurizio Volterrani33, Stephan Von Haehling41,42, Arno Hoes23.   

Abstract

The heart failure epidemic is growing and its prevention, in order to reduce associated hospital readmission rates and its clinical and economic burden, is a key issue in modern cardiovascular medicine. The present consensus document aims to provide practical evidence-based information to support the implementation of effective preventive measures. After reviewing the most common risk factors, an overview of the population attributable risks in different continents is presented, to identify potentially effective opportunities for prevention and to inform preventive strategies. Finally, potential interventions that have been proposed and have been shown to be effective in preventing HF are listed. The article has been co-published with permission in the European Journal of Preventive Cardiology and European Journal of Heart Failure. All rights reserved.
© The Author(s) 2022. The articles are identical except for minor stylistic and spelling differences in keeping with each journal’s style. Either citation can be used when citing this article.

Entities:  

Keywords:  Diabetes mellitus; Epidemiology; Heart failure; Population attributable risks; Prevention;  Arterial hypertension

Mesh:

Year:  2022        PMID: 35083485     DOI: 10.1093/eurjpc/zwab147

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  1 in total

1.  Metoprolol Mitigates Ischemic Heart Remodeling and Fibrosis by Increasing the Expression of AKAP5 in Ischemic Heart.

Authors:  Feng Zhu; Qiushu Wang; Zhi Wang; Xu Zhang; Benkai Zhang; Hegui Wang
Journal:  Oxid Med Cell Longev       Date:  2022-10-04       Impact factor: 7.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.